Profit

Sell Aurobindo Pharma For Target Of Rs 600: Sumeet Bagadia

PUBLISHED ON: December 20, 2016 | Duration: 13 min, 45 sec

facebooktwitteremailkoo
loading..
Sumeet Bagadia, associate director at Choice Broking, says Aurobindo Pharma is looking weak and it has support around Rs 660-665 levels. If these levels are taken away there can be a sharp selloff in the counter wherein it can fall 8-10 per cent to Rs 600, adds Mr Bagadia.
ALSO WATCH
No Manish Sisodia In 1st Chargesheet In Delhi Liquor Policy Case

................................ Advertisement ................................

Short videosBy Firework

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com